Alle verbonden artikelen

Everolimus plus exemestane as first-line therapy in HR(+), HER2 (-) advanced breast cancer in BOLERO-2.

Auteurs : Beck JT, Hortobagyi GN, Campone M, Lebrun F, Deleu I, Rugo HS, Pistilli B, Masuda N, Hart L, Melichar B, Dakhil S, Geberth M, Nunzi M, Heng DY, Brechenmacher T, El-Hashimy M, Douma S, Ringeisen F, Piccart-Gebhart M
Jaar : 2014
Journal : Breast Cancer Res. Treat.
Volume : 143(3)
Pagina's : 459-67

Locoregional treatment of breast cancer during pregnancy.

Auteurs : Toesca A, Gentilini O, Peccatori F, Azim HA, Amant F
Jaar : 2014
Journal : Gynecol Surg
Volume : 11(4)
Pagina's : 279-284

Biology of breast cancer during pregnancy using genomic profiling.

Auteurs : Azim HA, Brohée S, Peccatori FA, Desmedt C, Loi S, Lambrechts D, Dell orto P, Majjaj S, Jose V, Rotmensz N, Ignatiadis M, Pruneri G, Piccart-Gebhart M, Viale G, Sotiriou C
Jaar : 2014
Journal : Endocr Relat Cancer
Volume : 21
Pagina's : 545-54

Evaluating the physiological reserves of older patients with cancer: the value of potential biomarkers of aging?

Auteurs : Pallis AG, Hatse S, Brouwers B, Pawelec G, Falandry C, Wedding U, Dal Lago L, Repetto L, Ring A, Wildiers H
Jaar : 2014
Journal : J Geriatr Oncol
Volume : 5(2)
Pagina's : 204-18

Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry.

Auteurs : Bartsch R, Frings S, Marty M, Awada A, Berghoff AS, Conte P, Dickin S, Enzmann H, Gnant M, Hasmann M, Hendriks HR, Llombart A, Massacesi C, Von Minckwitz G, Penault-Llorca F, Scaltriti M, Yarden Y, Zwierzina H, Zielinski CC
Jaar : 2014
Journal : Ann Oncol
Volume : 25(4)
Pagina's : 773-80

Anemia in the elderly.

Auteurs : Maerevoet M, Sattar L, Bron D, Gulbis B, Pepersack T
Jaar : 2014
Journal : Rev Med Brux
Volume : 35(4)
Pagina's : 361-7

Tumour-associated osteomalacia and hypoglycaemia in a patient with prostate cancer: is Klotho involved?

Auteurs : Latifyan SB, Vanhaeverbeek M, Klastersky J
Jaar : 2014
Journal : BMJ Case Rep
Volume : 2014(null)

Information perception, wishes, and satisfaction in ambulatory cancer patients under active treatment: patient-reported outcomes with QLQ-INFO25.

Auteurs : Pinto AC, Ferreira-Santos F, Dal Lago L, de Azambuja E, Pimentel FL, Piccart-Gebhart M, Razavi D
Jaar : 2014
Journal : Ecancermedicalscience
Volume : 8(null)
Pagina's : 425

Case Report: Mammary and rectal metastases from an ovarian cancer: report of two cases and review of literature

Auteurs : Amzerin M, Garcia C, Stanciu C, Veys I, Awada A, Errihani H, Gombos A
Jaar : 2014
Journal : F1000Res
Volume : 3
Pagina's : 255

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.

Auteurs : Bottai G, Lehmann-Che J, Kéri G, Orfi L, Iwamoto T, Desmedt C, Bianchini G, Turner NC, de Thè H, André F, Sotiriou C, Hortobagyi GN, Di Leo A, Pusztai L, Santarpia L
Jaar : 2014
Journal : Mol oncol
Volume : 8(3)
Pagina's : 508-19

Febrile Neutropenia in pocket Books for Cancer Supportive Care (2014), Springer Healthcare

Auteurs : Klastersky J
Jaar : 2014
Journal : Book
Volume : -
Pagina's : -

Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.

Auteurs : Fumagalli D, Blanchet-Cohen A, Brown D, Desmedt C, Gacquer D, Michiels S, Rothé F, Majjaj S, Salgado R, Larsimont D, Ignatiadis M, Maetens M, Piccart-Gebhart M, Detours V, Sotiriou C, Haibe-Kains B
Jaar : 2014
Journal : BMC Genomics
Volume : 15(1)
Pagina's : 1008

Trastuzumab-Associated Cardiac Events at 8 Years of Median Follow-Up in the Herceptin Adjuvant Trial (BIG 1-01).

Auteurs : de Azambuja E, Procter MJ, van Veldhuisen DJ, Agbor-Tarh D, Metzger-Filho O, Steinseifer J, Untch M, Smith IE, Gianni L, Baselga J, Jackisch C, Cameron DA, Bell R, Leyland-Jones B, Dowsett M, Gelber Rd, Piccart-Gebhart M, Suter TM
Jaar : 2014
Journal : J. Clin. Oncol.
Volume : 32(20)
Pagina's : 2159-65

Biology of breast cancer in young women.

Auteurs : Azim HA, Partridge AH
Jaar : 2014
Journal : Breast Cancer Res
Volume : 16(4)
Pagina's : 427

Cardiotoxicity of systemic agents used in breast cancer.

Auteurs : Ades F, Zardavas D, Pinto AC, Criscitiello C, Aftimos P, de Azambuja E
Jaar : 2014
Journal : Breast
Volume : 23(4)
Pagina's : 317-328

Adverse events of targeted therapies.

Auteurs : Klastersky J
Jaar : 2014
Journal : Curr Opin Oncol
Volume : 26(4)
Pagina's : 395-402

Deciphering clonality in aneuploid tumors using SNP array and sequencing data.

Auteurs : Lönnstedt IM, Caramia F, Li J, Fumagalli D, Salgado R, Rowan A, Salm M, Kanu N, Savas P, Horswell S, Gade S, Loibl S, Neven P, Sotiriou C, Swanton C, Loi S, Speed TP
Jaar : 2014
Journal : Genome Biol.
Volume : 15(9)
Pagina's : 470

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.

Auteurs : Deleporte A, Paesmans M, Garcia C, Vandeputte C, Lemort M, Engelholm JL, Hoerner F, Aftimos P, Awada A, Charette N, Machiels G, Piccart-Gebhart M, Flamen P, Hendlisz A
Jaar : 2014
Journal : BMC Cancer
Volume : 14(1)
Pagina's : 385

A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumors.

Auteurs : Raymond E, Alexandre J, Faivre S, Goldwasser F, Besse-Hammer T, Gianella-Borradori A, Jego V, Trandafir L, Rejeb N, Awada A
Jaar : 2014
Journal : Invest New Drugs
Volume : 32(1)
Pagina's : 94-103

Adjuvant and neoadjuvant chemotherapy regimens in breast cancer: summary from the BSMO breast cancer task force meeting.

Auteurs : Wildiers H, Denys H, Fontaine C, Awada A
Jaar : 2014
Journal : Belgian J Medical Oncology
Volume : 8(4)
Pagina's : 116-124